Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alpine Immune Sciences Inc (NQ: ALPN )

64.57 +0.02 (+0.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,180,173
Open 64.57
Bid (Size) 64.55 (2)
Ask (Size) 64.99 (3)
Prev. Close 64.55
Today's Range 64.56 - 64.63
52wk Range 6.710 - 64.70
Shares Outstanding 23,914,879
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Vertex is broadening its portfolio. 
Via The Motley Fool
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
These stocks could be near major inflection points. 
Via The Motley Fool

Performance

YTD
+239.84%
+239.84%
1 Month
+71.96%
+71.96%
3 Month
+231.47%
+231.47%
6 Month
+637.94%
+637.94%
1 Year
+801.82%
+801.82%

More News

Read More
3 Relatively Safe Growth Stocks You Can Buy and Hold
Via The Motley Fool
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
Via The Motley Fool
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 4/16
Via Investor Brand Network
Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?
Via InvestorPlace
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
Via The Motley Fool
Could This Stock Be the Next Biotech Buyout?
Via The Motley Fool
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN
From Kahn Swick & Foti, LLC
Via Business Wire
Stock Market Sends Mixed Signals; Nvidia, Inflation, Mideast Fears In Focus: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Stocks Surge, Goldgasms To Record High After "Adjusted" PPI Sparks Buying Frenzy
Via Talk Markets
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
Via Benzinga
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) Near Top of Volume Charts in Thursday Trading
Via Investor Brand Network
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Alpine Immune Sciences Inc. (NASDAQ: ALPN) Records 52-Week High Thursday Morning
Via Investor Brand Network
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
Via InvestorPlace
Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
Via Investor's Business Daily
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Wall Street Braces For Another Red Day Ahead Of More Inflation Data While Bitcoin Holds Above $70K: Analyst Sees Any Pullback As 'Phenomenal Buying Opportunity'
Via Benzinga
Topics Economy
Exposures Interest Rates
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.